VANGUARD GROUP INC - HARPOON THERAPEUTICS INC ownership

HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 80 filers reported holding HARPOON THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of HARPOON THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$818,736
-4.6%
1,153,1480.0%0.00%
Q1 2023$858,173
+2.5%
1,153,1480.0%0.00%
Q4 2022$836,839
-25.1%
1,153,148
+0.0%
0.00%
Q3 2022$1,118,000
-51.5%
1,152,630
-4.4%
0.00%
Q2 2022$2,303,000
-64.0%
1,205,751
-6.4%
0.00%
Q1 2022$6,402,000
-32.4%
1,288,202
+2.7%
0.00%
Q4 2021$9,466,000
-6.8%
1,253,810
-2.5%
0.00%
Q3 2021$10,160,000
-41.7%
1,286,182
+2.4%
0.00%
Q2 2021$17,419,000
-29.9%
1,255,845
+5.7%
0.00%
-100.0%
Q1 2021$24,856,000
+134.9%
1,188,126
+86.5%
0.00%
Q4 2020$10,583,000
+10.8%
637,168
+13.3%
0.00%
Q3 2020$9,553,000
+27.1%
562,283
+24.2%
0.00%
Q2 2020$7,517,000
+60.8%
452,760
+12.2%
0.00%
Q1 2020$4,674,000
-19.1%
403,572
+3.3%
0.00%
Q4 2019$5,778,000
+8.8%
390,692
+0.4%
0.00%
Q3 2019$5,313,000
+74.4%
388,951
+66.0%
0.00%
Q2 2019$3,047,000
+289.1%
234,377
+183.3%
0.00%
Q1 2019$783,00082,7330.00%
Other shareholders
HARPOON THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 4,524,425$75,105,00022.35%
MPM BioImpact LLC 3,898,422$64,714,00017.21%
New Leaf Venture Partners, L.L.C. 2,921,405$48,495,00013.92%
Avidity Partners Management LP 1,206,351$20,025,0001.28%
Consonance Capital Management LP 844,162$14,013,0000.84%
Orbimed Advisors 1,835,704$30,473,0000.43%
Artal Group S.A. 900,000$14,940,0000.42%
Cormorant Asset Management, LP 645,257$10,711,0000.41%
DAFNA Capital Management LLC 85,119$1,413,0000.41%
Soleus Capital Management, L.P. 30,886$512,0000.29%
View complete list of HARPOON THERAPEUTICS INC shareholders